1Y Close · As of Aug 26, 2026
Curiox Biosystems operates in the Medical, Precision & Optical sector.
Legal name: Curiox Biosystems Co., Ltd.
In fiscal year 2025, Curiox Biosystems (445680) reported revenue of 5.2 billion KRW, up 12.3% from 4.6 billion KRW a year earlier.
Operating profit was -12.3 billion KRW and net income was -27.2 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 941.5 billion KRW, with a P/B of 17.83.
These figures can be verified in the DART filing (receipt no. 20260323001056).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 5.2B | -12.3B | -27.2B |
| 2024 | 4.6B | -13.4B | -8.1B |
| 2023 | 6.8B | -10.6B | -10.0B |
| 2022 | 7.2B | -11.4B | -11.5B |
| 2021 | 5.5B | -8.3B | -14.5B |
Recent Filings
Semi-Annual Report (2026.06)
Stock Option Grant Report
Officer/Major Shareholder Ownership Report
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-11 | Stock Option Grant Report |
| 2026-08-10 | Officer/Major Shareholder Ownership Report |
| 2026-08-10 | Large Shareholding Report (General) |
| 2026-08-07 | Officer/Major Shareholder Ownership Report |